Senior insider sale
XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$786.5K
107.50K shares
What this filing means
JOHNSON JOHN plans to sell 107.50K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $786.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2025ACC: 0001950047-25-005741
Director
Since Oct 2021
107.50K
Shares to sell
$786.5K
Approx. market value
107.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted Stock
Not Applicable
6/4/2025
50KRestricted Stock
Not Applicable
6/5/2024
42.50KRestricted Stock
Not Applicable
6/7/2023
15KTotal acquired107.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/4/2025 | Restricted Stock Not Applicable | 50K | — |
6/5/2024 | Restricted Stock Not Applicable | 42.50K | — |
6/7/2023 | Restricted Stock Not Applicable | 15K | — |
| Total | 107.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
107.50K
Market value
$786.5K
8/13/2025
Total
Units
107.50K
Value
$786.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/13/2025 | 107.50K | $786.5K | NASDAQ | Planned |
| Total | 107.50K | $786.5K | ||